Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

196 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Youth-onset type 2 diabetes in Israel: A national cohort.
Zuckerman Levin N, Cohen M, Phillip M, Tenenbaum A, Koren I, Tenenbaum-Rakover Y, Admoni O, Hershkovitz E, Haim A, Mazor Aronovitch K, Zangen D, Strich D, Brener A, Yeshayahu Y, Schon Y, Rachmiel M, Ben-Ari T, Levy-Khademi F, Tibi R, Weiss R, Lebenthal Y, Pinhas-Hamiel O, Shehadeh N. Zuckerman Levin N, et al. Among authors: shehadeh n. Pediatr Diabetes. 2022 Sep;23(6):649-659. doi: 10.1111/pedi.13351. Epub 2022 Jun 1. Pediatr Diabetes. 2022. PMID: 35521999
Increase in the incidence of type 1 diabetes in Israeli children following the Second Lebanon War.
Zung A, Blumenfeld O, Shehadeh N, Dally Gottfried O, Tenenbaum Rakover Y, Hershkovitz E, Gillis D, Zangen D, Pinhas-Hamiel O, Hanukoglu A, Rachmiel M, Shalitin S; Israel IDDM Registry Study Group. Zung A, et al. Among authors: shehadeh n. Pediatr Diabetes. 2012 Jun;13(4):326-33. doi: 10.1111/j.1399-5448.2011.00838.x. Epub 2011 Dec 13. Pediatr Diabetes. 2012. PMID: 22151880
A Phase II, Double-Blind, Randomized, Placebo-Controlled, Multicenter Study Evaluating the Efficacy and Safety of Alpha-1 Antitrypsin (AAT) (Glassia®) in the Treatment of Recent-Onset Type 1 Diabetes.
Lebenthal Y, Brener A, Hershkovitz E, Shehadeh N, Shalitin S, Lewis EC, Elias D, Haim A, Barash G, Loewenthal N, Zuckerman-Levin N, Stein M, Tov N, Rachmiel M. Lebenthal Y, et al. Among authors: shehadeh n. Int J Mol Sci. 2019 Nov 29;20(23):6032. doi: 10.3390/ijms20236032. Int J Mol Sci. 2019. PMID: 31795482 Free PMC article. Clinical Trial.
Prediction of Personal Glycemic Responses to Food for Individuals With Type 1 Diabetes Through Integration of Clinical and Microbial Data.
Shilo S, Godneva A, Rachmiel M, Korem T, Kolobkov D, Karady T, Bar N, Wolf BC, Glantz-Gashai Y, Cohen M, Zuckerman Levin N, Shehadeh N, Gruber N, Levran N, Koren S, Weinberger A, Pinhas-Hamiel O, Segal E. Shilo S, et al. Among authors: shehadeh n. Diabetes Care. 2022 Mar 1;45(3):502-511. doi: 10.2337/dc21-1048. Diabetes Care. 2022. PMID: 34711639
The Gut Microbiome of Adults With Type 1 Diabetes and Its Association With the Host Glycemic Control.
Shilo S, Godneva A, Rachmiel M, Korem T, Bussi Y, Kolobkov D, Karady T, Bar N, Wolf BC, Glantz-Gashai Y, Cohen M, Zuckerman-Levin N, Shehadeh N, Gruber N, Levran N, Koren S, Weinberger A, Pinhas-Hamiel O, Segal E. Shilo S, et al. Among authors: shehadeh n. Diabetes Care. 2022 Mar 1;45(3):555-563. doi: 10.2337/dc21-1656. Diabetes Care. 2022. PMID: 35045174
A randomized clinical trial of the efficacy and safety of sitagliptin as initial oral therapy in youth with type 2 diabetes.
Shankar RR, Zeitler P, Deeb A, Jalaludin MY, Garcia R, Newfield RS, Samoilova Y, Rosario CA, Shehadeh N, Saha CK, Zhang Y, Zilli M, Scherer LW, Lam RLH, Golm GT, Engel SS, Kaufman KD. Shankar RR, et al. Among authors: shehadeh n. Pediatr Diabetes. 2022 Mar;23(2):173-182. doi: 10.1111/pedi.13279. Epub 2021 Dec 22. Pediatr Diabetes. 2022. PMID: 34779087 Clinical Trial.
196 results